|Articles|September 1, 2019
- Pharmaceutical Executive-09-01-2019
- Volume 39
- Issue 9
Pharmaceutical Executive, September 2019 Issue (PDF)
Click the title above to open the Pharmaceutical Executive September 2019 issue in an interactive PDF format.
Advertisement
Articles in this issue
about 6 years ago
Pharm Exec's 18th Annual Industry Auditabout 6 years ago
Product Development: The Optimizer’s Curseabout 6 years ago
Setting Your Launch Pathabout 6 years ago
Pre-launch Prep: The Modern Protocolabout 6 years ago
The Murky Outlook for Generic Drugsabout 6 years ago
Post-Launch Birthday: The Time to Refineabout 6 years ago
Product Launch: Five Paths Forwardabout 6 years ago
Once Upon a Brandabout 6 years ago
Country Report: Chinaabout 6 years ago
Other Products to WatchNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
AbbVie Raises 2025 Profit Forecast Following Increased Demand for Immunology Treatments
2
Eli Lilly to Submit Oral GLP-1 for FDA Priority Review Program: Report
3
Pharmaceutical Executive Daily: Novo Nordisk's Unsolicited Acquisition Proposal
4
Pharmaceutical Executive Presents: Most Favored Nation Order - How Trump Is Disrupting Pharma
5
